Mehdi Parsanahad

Mehdi Parsanahad

Auto-generated profile, based on publicly available information

Mehdi Parsanahad

Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran, ajums.ac.ir

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
ARAli Ramezani
Ali Ramezani
MNMehdi Parsa Nahad
Mehdi Parsa Nahad
EFEbrahim Faghihloo
Ebrahim Faghihloo

1 May 2018 in Microbial Pathogenesis
Verified
Journal Article
Closed access
MMManoochehr Makvandi
Manoochehr Makvandi
ATAli Teimoori
Ali Teimoori
MNMehdi Parsa Nahad
Mehdi Parsa Nahad
AKAli Khodadadi
Ali Khodadadi
MCMohammad Ghasemi Deh Cheshmeh
Mohammad Ghasemi Deh Cheshmeh
MZMilad Zandi
Milad Zandi

27 October 2020 in Iranian Journal of Allergy, Asthma and Immunology
Verified
Journal Article
Closed access
FAFarhad Abolnezhadian
Farhad Abolnezhadian
MMManoochehr Makvandi
Manoochehr Makvandi
SASeyed Mohammad Alavi
Seyed Mohammad Alavi
AAAzarakhsh Azaran
Azarakhsh Azaran
SJShahram Jalilian
Shahram Jalilian
KAKambiz AhmadiAngali
Kambiz AhmadiAngali
The emergence of a highly pathogenic virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) accounts for severe pneumonia throughout the world. More than 7 million world population have been infected with SARS-CoV-2, and the number of deaths is increasing every day. This study aimed to evaluate the frequency of SARS-CoV-2 in hospitalized patients with acute respiratory infection (ARI). During an outbreak of the SARS-CoV-2, the nasopharyngeal and oropharyngeal swabs were collected from 909 hospitalized patients with severe pneumonia, including 517 (56.9%) males and 392 (43.1%) females. All the collected samples were from different cities of Khuzestan province from 19 February to- 27 March 2020. The RNA was extracted from samples and subjected to real-time polymerase chain reaction (PCR) tests for the detection of the SARS-CoV-2. Simultaneously, the computerized tomography (CT) scan was tested for the presence of ground-glass opacity in the lung among the patients. Of the total number of 909 specimens, 328 (36.08%) cases, including 185 (20.35%) females and 143 (15.73%) males, were positive for the SARS-CoV-2 while, 581 (63.9%) cases, including 374 (41.14%) males and 207 (22.77%) were negative for the SARS-CoV-2 by real-time PCR (p=0.001).Four hundred sixteen (45.76%) cases were positive for ground-glass opacity in the lung by CT scan, while 328/909 (36.08%) trials proved positive for SARS-CoV-2 by the real-time PCR (p=0.003). In this study, 36.08% of patients were positive for SARS-CoV-2. Although the results of positive cases by CT scan showed higher than real-time PCR, screening the SARS-CoV-2 with a real-time PCR method is the first line of choice.

1 October 2017
Verified
Journal Article
Open access
PDF file
AMali mard
ali mard
GAGhaidafeh Akbari
Ghaidafeh Akbari
EMEsrafil Mansouri
Esrafil Mansouri
MPMahdi Parsanahad
Mahdi Parsanahad
Objective(s): The objectives of the current study were to evaluate the effects of hepatic ‎ischemia/reperfusion (IR) injury on the activity of antioxidant enzymes, biochemical factors, and ‎histopathological changes in rat kidney, and to investigate the effect of crocin on IR-‎related changes. Materials and Methods: Thirty-two male Wistar rats were randomly allocated into four groups (n=8). They were ‎sham-operated, IR, crocin pre-treatment, and crocin pretreatment+IR groups. Sham-operated ‎and Crocin pre-treatment groups received normal saline (N/S, 2 ml/day) and crocin (200 mg/kg) ‎for seven consecutive days intraperitoneally (IP), respectively, then rats underwent laparotomy, only. ‎IR and crocin pretreatment+IR groups received N/S and crocin with the same dose, time, and route, ‎respectively, then rats underwent partial (70%) ischemia for 45 min that was followed by reperfusion ‎for 60 min. At the end of the experiment, kidney specimens were taken for histopathological and ‎antioxidant evaluations and also blood samples were obtained for biochemical analysis. Results: The results of the present study showed that crocin pre-treatment significantly increased ‎the activity of antioxidants, decreased the serum levels of liver enzymes and blood urea nitrogen ‎following IR-induced hepatic injury. Crocin also ameliorated kidney´s histopathological ‎disturbance beyond IR-induced hepatic injury. Conclusion: Crocin as an antioxidant agent protected renal insult following liver IR injury by ‎increasing the activity of antioxidant enzymes, reducing serum levels of liver enzymes, and ‎improving histopathological changes.‎

14 February 2021 in Iranian Journal of Allergy, Asthma and Immunology
Verified
Journal Article
Closed access
ZAZahra Abdoli
Zahra Abdoli
MAMohammad-Ali Assarehzadegan
Mohammad-Ali Assarehzadegan
MPMohammad Hassan Pipelzadeh
Mohammad Hassan Pipelzadeh
SISara Iranparast
Sara Iranparast
NGNader Dashti Gerdabi
Nader Dashti Gerdabi
AKAli Khodadadi
Ali Khodadadi
Leukemia inhibitory factor (LIF) is a multi-functional cytokine secreted from cells such as lymphocytes and hepatocytes. This study aimed to evaluate the effect of LIF on natural killer group 2 member D (NKG2D) receptors' expression and presentation on natural killer (NK) cells. For this purpose, peripheral blood mononuclear cells taken from 4 young male healthy blood donors were isolated and the effect of LIF (25 ng/mL) after 12, 24, and 48 hours of incubation, on NKG2D receptors expression and presentation was investigated using flow cytometry and real-time-polymerase chain reaction (PCR). All of the steps of the experiment were performed in duplicate. After periods of 12, 24, and 48 hours, LIF reduced both the expression and presentation of the NKG2D receptor on NK cells. The results suggest that this cytokine has a direct modulating activity on the body’s immune response through suppression of NKG2D receptor expression and presentation on NK cells.

1 January 2018 in Microbial Pathogenesis
Verified
Journal Article
Closed access
MNMehdi Parsa Nahad
Mehdi Parsa Nahad
MMManoochehr Makvandi
Manoochehr Makvandi
ATAli Teimoori
Ali Teimoori
SJShahram Jalilian
Shahram Jalilian
GKGholam Abbas Kaydani
Gholam Abbas Kaydani
SMSara Mahmoodi
Sara Mahmoodi